SCHEMBL24981976

SCHEMBL24981976

Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CN(C(=O)OC(C)(C)C)CCCO4)c(F)c3)cc21

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CTSC P53634 20/20 0.58
▸ CTSK P43235 1/20 0.51
▸ KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28989283 1.00 CTSC (0.58) CTSCCTSKKCNH2
SCHEMBL25369429 1.00 CTSC (0.58) CTSCCTSKKCNH2
SCHEMBL29455307 0.95 CTSC (0.53) CTSCCTSKKCNH2
SCHEMBL28989371 0.93 CTSC (0.49) CTSCCTSKKCNH2
SCHEMBL28989376 0.93 CTSC (0.49) CTSCCTSKKCNH2
SCHEMBL28989374 0.93 CTSC (0.49) CTSCCTSKKCNH2
SCHEMBL30738864 0.93 CTSC (0.52) CTSCCTSKKCNH2
SCHEMBL25146472 0.92 CTSC (0.55) CTSCCTSKKCNH2
SCHEMBL28989310 0.92 CTSC (0.55) CTSCCTSKKCNH2
SCHEMBL28989313 0.92 CTSC (0.55) CTSCCTSKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062420-A1 NOVEL DPP1 INHIBITORS AND USES THEREOF INSMED INC (US) 2026-03-05 — — US disclosed
US-20250188067-A1 SALT AND CRYSTAL FORM OF DIPEPTIDYL PEPTIDASE INHIBITOR COMPOUND HAISCO PHARMACEUTICALS PTE. LTD. (SG) 2025-06-12 — — US disclosed
US-20250179060-A1 PREPARATION METHOD OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAISCO PHARMACEUTICALS PTE. LTD. (SG) 2025-06-05 — — US disclosed
EP-4561565-A2 NOVEL DPP1 INHIBITORS AND USES THEREOF Insmed Incorporated (US) 2025-06-04 — — EP disclosed
EP-4484414-A1 SALT AND CRYSTAL FORM OF DIPEPTIDYL PEPTIDASE INHIBITOR COMPOUND Haisco Pharmaceuticals Pte. Ltd. (SG) 2025-01-01 — — EP disclosed
EP-4484423-A1 PREPARATION METHOD OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Haisco Pharmaceuticals Pte. Ltd. (SG) 2025-01-01 — — EP disclosed
CN-118742547-A Preparation method of nitrogen-containing heterocyclic compound 西藏海思科制药有限公司 2024-10-01 — — CN disclosed
WO-2024193695-A1 PHARMACEUTICAL COMPOSITION CONTAINING DIPEPTIDYL PEPTIDASE SMALL MOLECULE INHIBITOR 西藏海思科制药有限公司 2024-09-26 — — WO disclosed
CN-118660873-A Salts and crystalline forms of dipeptidyl peptidase inhibitor compounds 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
WO-2024026433-A2 NOVEL DPP1 INHIBITORS AND USES THEREOF INSMED INCORPORATED (US) 2024-02-01 — — WO disclosed
US-11807635-B2 Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof HAISCO PHARMACEUTICALS PTE. LTD. (SG) 2023-11-07 — — US disclosed
WO-2023160542-A1 SALT AND CRYSTAL FORM OF DIPEPTIDYL PEPTIDASE INHIBITOR COMPOUND 四川海思科制药有限公司 2023-08-31 — — WO disclosed
WO-2023160541-A1 PREPARATION METHOD OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND 四川海思科制药有限公司 2023-08-31 — — WO disclosed
CN-115996923-A Nitrile derivative as dipeptidyl peptidase 1 inhibitor and application thereof 四川海思科制药有限公司 2023-04-21 — — CN disclosed
US-20230121807-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF HAISCO PHARMACEUTICALS PTE. LTD (SG) 2023-04-20 — — US disclosed
EP-4129989-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF Haisco Pharmaceuticals Pte. Ltd. (SG) 2023-02-08 — — EP disclosed
WO-2022042591-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF 四川海思科制药有限公司 2022-03-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807635-B2 Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof DPP4, DPP3, DPP9 CTSC 4/4885CTSK 454/4885KCNH2 4526/4885
US-20250179060-A1 PREPARATION METHOD OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND NIT2, NAAA, NUDT21 CTSC 3581/4885CTSK 2791/4885KCNH2 1593/4885
US-20250188067-A1 SALT AND CRYSTAL FORM OF DIPEPTIDYL PEPTIDASE INHIBITOR COMPOUND DPP7, DPP4, DPP8 CTSC 9/4885CTSK 613/4885KCNH2 2186/4885
US-20260062420-A1 NOVEL DPP1 INHIBITORS AND USES THEREOF DPP4, DPP3, DPP7 CTSC 7/4885CTSK 1272/4885KCNH2 2268/4885
US-20230121807-A1 NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF DPP4, DPP3, DPP9 CTSC 4/4885CTSK 454/4885KCNH2 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback